Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety
Related Posts
Andreazza AC, Behnke A, Bolanos JP, Juan-Sanz J, Epel E, Evans MK, Barrett LF, Gyllenhammer LE, Hirabayashi Y, Hirano M, Hollis F, Kelly DP, Kempes[...]
Shih RM, Harary M, Bergsneider M, Wang M, Heaney AP, Wu KC, Prevedello DM, Evans JJ, Chicoine MR, Kim AH, Silverstein JM, Karsy M, Van[...]
Yun JS, Feo A, Chew L, Feng J, Hutchins E, Stein-Merlob AF, Yang EH, Lechner MG, Tsui E. Longitudinal Outcomes in Immune Checkpoint Inhibitor-Associated Uveitis.[...]